Article
The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.
The Journal of clinical endocrinology and metabolism - 1 Nov 2013
Thosani Sonali, Ayala-Ramirez Montserrat, Palmer Lynn, Hu Mimi I, Rich Thereasa, Gagel Robert F, Cote Gilbert, Waguespack Steven G, Habra Mouhammed Amir, Jimenez Camilo
Abstract excerpt
CONTEXT: Pheochromocytoma (PHEO) occurs in 50% of patients with multiple endocrine neoplasia type 2 (MEN2). It is unknown if the presence of PHEO is associated with more aggressive medullary thyroid cancer (MTC). OBJECTIVE: To present our experience with MEN2 PHEO and evaluate whether PHEO impacts MTC overall survival in patients with RET codon 634 mutations. DESIGN: We performed a retrospective chart review of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
